Michael Messinger
Director/Board Member presso FILAMENT HEALTH CORP.
Patrimonio netto: 1 $ in data 31/03/2024
Profilo
Michael Messinger is currently the Director at Filament Health Corp.
He previously worked as the Finance Director at Lexicon Pharmaceuticals, Inc. from 2001 to 2012.
Before that, he was an Auditor at Ernst & Young LLP from 1996 to 1999 and a Controller at Coelacanth Corp.
from 1999 to 2001.
From 2012 to 2023, he served as the President, Chief Executive & Operating Officer at ContraFect Corp.
Mr. Messinger obtained his undergraduate degree from the University of Michigan.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CONTRAFECT CORP.
0.00% | 06/09/2023 | 23 ( 0.00% ) | 1 $ | 31/03/2024 |
Posizioni attive di Michael Messinger
| Società | Posizione | Inizio |
|---|---|---|
| FILAMENT HEALTH CORP. | Director/Board Member | 28/03/2024 |
Precedenti posizioni note di Michael Messinger
| Società | Posizione | Fine |
|---|---|---|
| CONTRAFECT CORPORATION | Chief Executive Officer | 04/12/2023 |
| LEXICON PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/01/2012 |
Coelacanth Corp.
 Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Coelacanth Corp. is a company that researches drug development. The company is based in East Windsor, NJ. The company was founded by Robert Grubbs. Coelacanth was acquired by Lexicon Pharmaceuticals, Inc. on 2001-07-12 for $31.9 million. | Comptroller/Controller/Auditor | 01/01/2001 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01/01/1999 |
Formazione di Michael Messinger
| University of Michigan | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| CONTRAFECT CORPORATION | Health Technology |
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| FILAMENT HEALTH CORP. | Health Technology |
| Aziende private | 2 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Coelacanth Corp.
Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Coelacanth Corp. is a company that researches drug development. The company is based in East Windsor, NJ. The company was founded by Robert Grubbs. Coelacanth was acquired by Lexicon Pharmaceuticals, Inc. on 2001-07-12 for $31.9 million. | Commercial Services |
- Borsa valori
- Insiders
- Michael Messinger
